Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber)

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 4, 2009, Pages 523-529

  Hashiguchi, Kazuhiro ^a   Tang, Huaipeng ^b   Fujita, Toshio ^b   Suematsu, Kiyochika ^c,d   Gotoh, Minoru ^e   Okubo, Kimihiro ^f  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

^b Shinryo Corporation   (Japan)

^c Chamber Business Department   (Japan)

^d Samoncho Clinic   (Japan)

^e NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Bepotastine besilate; Cognitive function; Environmental exposure chamber; Japanese cedar pollinosis

Indexed keywords

BETOTASTINE; PLACEBO; ALLERGEN; ANTIALLERGIC AGENT; PIPERIDINE DERIVATIVE; PYRIDINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EPIPHORA; FEMALE; HUMAN; JAPANESE CEDAR; JOB PERFORMANCE; MALE; NASAL PRURITUS; NOSE OBSTRUCTION; NOSE SECRETION; OCULAR PRURITUS; POLLEN ALLERGY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SNEEZING; SYMPTOM; AIR POLLUTANT; AIR QUALITY CONTROL; DRUG EFFECT; HAY FEVER; IMMUNOLOGY; NOSE MUCOSA; NOSE MUCUS; ORAL DRUG ADMINISTRATION; POLLEN; PSYCHOLOGICAL ASPECT; SINGLE BLIND PROCEDURE; TABLET;

ADMINISTRATION, ORAL; AIR POLLUTANTS; ALLERGENS; ANTI-ALLERGIC AGENTS; ATMOSPHERE EXPOSURE CHAMBERS; COGNITION; FEMALE; HUMANS; MALE; NASAL LAVAGE FLUID; NASAL MUCOSA; PIPERIDINES; POLLEN; PYRIDINES; RHINITIS, ALLERGIC, SEASONAL; SINGLE-BLIND METHOD; TABLETS;

EID: 65649142972     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560902758368     Document Type: Article

References (16)

1. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003;91:288-296 (Pubitemid 37174163)
2. Bousquet J, Khaltaev N, Cruz AA, et al.; Aria Workshop Group. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
3. Practical Guideline for the Management of Allergic Rhinitis in Japan 2009, Committee of Practical Guideline for Management of Allergic Rhinitis (in Japanese). Tokyo: Life Science Publishing Co. Ltd; 2008
4. Baba S, Takasaka T, Baba K, et al. Clinical trial of TAU-284 (bepotastine besilate) on perennial allergic rhinitis - a double-blind study in comparison with terfenadine (in Japanese). J Clin Ther Med 1997;13:1307-1335
5. Tanaka T, Miyazaki S, Ishikawa K. Effects of Talion® on nasal obstruction in nasal allergy (in Japanese). Prog Med 2004;24:2037-2044
6. Baba S, Takasaka T, Baba K, et al. Long-term treatment of TAU-284 (betotastine besilate) on perennial allergic rhinitis (in Japanese). J Clin Ther Med 1997;13:1361-1382
7. Hashiguchi K, Tang H, Fujita T, et al. Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol 2009;149:141-149
8. Ito Y, Yoshizaki K, Hatta T. Cognitive dysfunction of traumatic brain injury (TBI) patients: a study of their information processing speed and attention by digit cancellation test (in Japanese). Stud Inform Sci 2001;14:43-57
9. Eccles R. Menthol: effects on nasal sensation of airflow and the drive to breathe. Curr Allergy Asthma Rep 2003;3:210-214 (Pubitemid 38899094)
10. Kaminuma O, Ogawa K, Kikkawa H, et al. A novel anti-allergic drug, bepotastine besilate, suppresses interleukin-5 production by human peripheral blood mononuclear cells. Biol Pharm Bull 1998;21:411-413 (Pubitemid 28216984)
11. Enomoto T, Ide T, Ogino S. Construction of an environmental exposure unit and investigation of the effects of cetirzine hydrochloride on symptoms of cedar pollinosis in Japan. J Investig Allergol Clin Immunol 2007;17:173-181 •• This study showed the efficacy and safety of cetirzine in JC pollinosis patients in an environmental exposure unit, which was first constructed in Japan. (Pubitemid 46890115)
12. Yokota H, Mizuuchi H, Maki T, et al. Phase I study of TAU-284 - single oral administration in healthy male volunteers (in Japanese). J Clin Ther Med 1997;13:1137-1153
13. Okubo K, Gotoh M, Shimada K, et al. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol 2005;136:148-154 • This paper showed that fexofenadine treatment in the patient with pollinosis improved overall quality of life during the peak pollinosis season in Japan. (Pubitemid 40463239)
14. Ohashi R, Kamikozawa Y, Sugiura M, et al. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate. Drug Metab Dispos 2006;34:793-799 • This study investigated the mechanism of the limited distribution in the brain with high intestinal absorption of bepotastine.
15. Tashiro M, Duan X, Kato M, et al. Brain histamine H1 receptor occupancy of orally administered antihistamins, bepotastin and diphenhydramine, measured by PET with 11C-doxepin. Br J Clin Pharmacol 2008;65:811-821 • This study first described histamine cerebral H1 receptor occupancy of bepotastine besilate as determined by positron emission tomography. (Pubitemid 351695231)
16. Kato M, Nishida A, Aga Y, et al. Pharmacokinetic and phamacodynamic evaluation of central effect of the novel antiallergic agent bepotastine besilate. Arzeimittelforschung 1997;47:1116-1124 (Pubitemid 27451895)